Hu Teh-Wei, Wagner Todd H, Bentkover Judith D, Leblanc Kristi, Zhou Steve Z, Hunt Timothy
Department of Health Economics, University of California, Berkeley, School of Public Health, Berkeley, California 94720, USA.
Urology. 2004 Mar;63(3):461-5. doi: 10.1016/j.urology.2003.10.037.
To update the cost of urinary incontinence (UI) for year 2000 and compare it with the cost of overactive bladder (OAB).
Using the cost-of-illness framework, disease epidemiologic data were combined with treatment rates, consequence probabilities, and average cost estimates. All costs reflect the costs during 2000.
The total cost of UI and OAB was 19.5 billion dollars and 12.6 billion dollars, respectively (year 2000 dollars). With UI, 14.2 billion dollars was borne by community residents and 5.3 billion dollars by institutional residents. With OAB, 9.1 and 3.5 billion dollars, respectively, was incurred by community and institutional residents.
OAB affected 34 million individuals compared with 17 million with UI. Despite the differences in epidemiology, the total and per-person costs of UI were higher than the OAB costs because OAB individuals without incontinent episodes incurred fewer costs, on average.
更新2000年尿失禁（UI）的成本，并将其与膀胱过度活动症（OAB）的成本进行比较。
使用疾病成本框架，将疾病流行病学数据与治疗率、后果概率和平均成本估计相结合。所有成本均反映2000年期间的成本。
UI和OAB的总成本分别为195亿美元和126亿美元（2000年美元）。对于UI，社区居民承担142亿美元，机构居民承担53亿美元。对于OAB，社区和机构居民分别产生91亿美元和35亿美元。
与1700万UI患者相比，OAB影响了3400万人。尽管流行病学存在差异，但UI的总成本和人均成本高于OAB成本，因为没有尿失禁发作的OAB患者平均产生的成本较少。
